These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 26054809

  • 21. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
    Jang SE, Hyam SR, Han MJ, Kim SY, Lee BG, Kim DH.
    J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
    [Abstract] [Full Text] [Related]

  • 22. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
    Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH.
    Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
    [Abstract] [Full Text] [Related]

  • 23. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages.
    Kim TW, Joh EH, Kim B, Kim DH.
    Int Immunopharmacol; 2012 Jan; 12(1):110-6. PubMed ID: 22107725
    [Abstract] [Full Text] [Related]

  • 24. Ginsenoside Rg1 regulates innate immune responses in macrophages through differentially modulating the NF-κB and PI3K/Akt/mTOR pathways.
    Wang Y, Liu Y, Zhang XY, Xu LH, Ouyang DY, Liu KP, Pan H, He J, He XH.
    Int Immunopharmacol; 2014 Nov; 23(1):77-84. PubMed ID: 25179784
    [Abstract] [Full Text] [Related]

  • 25. Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice.
    Oh HA, Kim DE, Choi HJ, Kim NJ, Kim DH.
    Biol Pharm Bull; 2015 Nov; 38(2):331-5. PubMed ID: 25747994
    [Abstract] [Full Text] [Related]

  • 26. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages.
    Bao S, Zou Y, Wang B, Li Y, Zhu J, Luo Y, Li J.
    Int Immunopharmacol; 2015 Sep; 28(1):429-34. PubMed ID: 26122136
    [Abstract] [Full Text] [Related]

  • 27. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages.
    Jang SE, Han MJ, Kim SY, Kim DH.
    Int Immunopharmacol; 2014 Jul; 21(1):186-92. PubMed ID: 24815859
    [Abstract] [Full Text] [Related]

  • 28. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
    Lee IA, Park YJ, Yeo HK, Han MJ, Kim DH.
    J Agric Food Chem; 2010 Oct 27; 58(20):10929-34. PubMed ID: 20923188
    [Abstract] [Full Text] [Related]

  • 29. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora.
    Long J, Liu XK, Kang ZP, Wang MX, Zhao HM, Huang JQ, Xiao QP, Liu DY, Zhong YB.
    Eur J Pharmacol; 2022 Feb 15; 917():174742. PubMed ID: 34999087
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice.
    Lee IA, Kim EJ, Kim DH.
    Planta Med; 2012 Jun 15; 78(9):896-8. PubMed ID: 22538477
    [Abstract] [Full Text] [Related]

  • 31. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin.
    Min JK, Lee CH, Jang SE, Park JW, Lim SJ, Kim DH, Bae H, Kim HJ, Cha JM.
    J Gastroenterol Hepatol; 2015 May 15; 30(5):858-65. PubMed ID: 25311527
    [Abstract] [Full Text] [Related]

  • 32. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
    Joh EH, Kim DH.
    Br J Pharmacol; 2011 Apr 15; 162(8):1731-42. PubMed ID: 21198552
    [Abstract] [Full Text] [Related]

  • 33. Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro.
    Song Y, Zhao F, Zhang L, Du Y, Wang T, Fu F.
    Fitoterapia; 2013 Dec 15; 91():173-179. PubMed ID: 24035860
    [Abstract] [Full Text] [Related]

  • 34. Amelioration of colitis in mice by Leuconostoc lactis EJ-1 by M1 to M2 macrophage polarization.
    Jang SE, Min SW.
    Microbiol Immunol; 2020 Feb 15; 64(2):133-142. PubMed ID: 31625616
    [Abstract] [Full Text] [Related]

  • 35. Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis.
    Yang XL, Guo TK, Wang YH, Huang YH, Liu X, Wang XX, Li W, Zhao X, Wang LP, Yan S, Wu D, Wu YJ.
    Int Immunopharmacol; 2012 Feb 15; 12(2):408-14. PubMed ID: 22227208
    [Abstract] [Full Text] [Related]

  • 36. Protective effects of ginsenoside Rg1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway.
    Ning C, Gao X, Wang C, Huo X, Liu Z, Sun H, Yang X, Sun P, Ma X, Meng Q, Liu K.
    Int Immunopharmacol; 2018 Aug 15; 61():266-276. PubMed ID: 29902710
    [Abstract] [Full Text] [Related]

  • 37. Ginsenoside metabolite 20(S)-protopanaxatriol from Panax ginseng attenuates inflammation-mediated NLRP3 inflammasome activation.
    Jiang J, Sun X, Akther M, Lian ML, Quan LH, Koppula S, Han JH, Kopalli SR, Kang TB, Lee KH.
    J Ethnopharmacol; 2020 Apr 06; 251():112564. PubMed ID: 31926987
    [Abstract] [Full Text] [Related]

  • 38. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect.
    Bae EA, Shin JE, Kim DH.
    Biol Pharm Bull; 2005 Oct 06; 28(10):1903-8. PubMed ID: 16204943
    [Abstract] [Full Text] [Related]

  • 39. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation.
    Gu W, Kim KA, Kim DH.
    Biol Pharm Bull; 2013 Oct 06; 36(1):102-7. PubMed ID: 23302642
    [Abstract] [Full Text] [Related]

  • 40. Ginsenoside Rg1 relieves experimental colitis by regulating balanced differentiation of Tfh/Treg cells.
    Jin J, Zhong Y, Long J, Wu T, Jiang Q, Wang H, Ge W, Zhao H, Liu D.
    Int Immunopharmacol; 2021 Nov 06; 100():108133. PubMed ID: 34543978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.